BPTSY (Biophytis) Interest Received


BPTSY Biophytis SA BPTSY
18 GF Score
Price $0.25
! 5 Warning Signs
View Full Analysis

What is Biophytis Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

BPTSY
18GF Score
Biophytis SA BPTSY
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biophytis Business Description

Address BC 9, Batiment A 4eme etage, 4 Place Jussieu, Sorbonne University, Paris, FRA, 75005
Biophytis SA is a France-based clinical-stage biotechnology company engaged in the development of drug candidates for the treatment of age-related and respiratory diseases. The company focuses on therapies that target degenerative processes associated with aging and improve functional outcomes. Its drug candidate, BIO101, is an orally administered small molecule under development for neuromuscular and respiratory indications, including sarcopenia, Duchenne muscular dystrophy (DMD), and respiratory failure.
18GF Score

Get the complete analysis for BPTSY

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price